Dr.
Beasley received a PhD in Life Sciences from the Queensland University
of Technology, Brisbane, Australia in 1999. Research in his lab
currently focuses on the molecular basis of phenotypic variations
between individual strains and major groups of flaviviruses, including
West Nile virus and other Japanese encephalitis complex viruses, the
dengue viruses, yellow fever virus, and tick-borne flaviviruses such as
Powassan virus. These studies aim to facilitate development of new and
improved vaccines, diagnostics and therapeutics for this important group
of emerging and re-emerging arthropod-borne viruses. He serves as a
member of the Executive Committee of the Sealy Institute for Vaccine
Sciences, is the Associate Director of the World Health Organization
Collaborating Center on Vaccine Research, Evaluation and Training on
Emerging Infectious Diseases, is a former Co-Director of UTMB's select
agent BSL3 laboratories, and is the former Director of the Galveston
National Laboratory Regulatory Compliance Core. He has been actively
involved in UTMB's preparations for the conduct of regulated nonclinical
studies at BSL3/4 since 2005, with an emphasis on development and use
of animal models for testing and approval of new vaccines and
therapeutics under the Animal Rule.
Search PubMed for Dr. Beasley's publications